Status:
COMPLETED
Effect of OM-85 BV on Wheezing Related Morbidity in Children With Recurrent Wheezing
Lead Sponsor:
Kecioren Education and Training Hospital
Conditions:
Asthma
Eligibility:
All Genders
6-6 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether OM-85 BV (Broncho-Vaxom)has any effect on respiratory infections, infection related wheezing attacks, beta-2 agonist use, duration of attacks and effe...
Detailed Description
Context: Respiratory infections are the major cause of wheezing attacks in children with recurrent wheezing or asthma in preschool age. OM-85 BV is an bacteria lysate which has been proven to prevent ...
Eligibility Criteria
Inclusion
- Children with recurrent wheezing who had at least 3 wheezing attacks in the last 6 months
- Children with asthma who had at least 3 wheezing attacks in the last 6 months
Exclusion
- Chronic lung disease
- Immun deficiency
- Malabsorption
- Anatomic abnormalities of the respiratory tract
- Gastroesophageal reflux disease
Key Trial Info
Start Date :
August 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00733226
Start Date
August 1 2007
End Date
October 1 2008
Last Update
July 16 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kecioren Education and Training Hospital
Ankara, Kec.oren, Turkey (Türkiye), 06380
2
Keçiören Education and Training Hospital
Ankara, Keçiören, Turkey (Türkiye), 06380